美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Neon Therapeutics Inc.

3.07

0.0000

成交量：- -

成交額：- -

市值：8,892.76萬

市盈率：-1.14

高：3.07

開：3.07

低：3.07

收：3.07

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

Neon Therapeutics Inc.

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.neontherapeutics.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Neon Therapeutics, Inc.於2013年10月根據特拉華州法律註冊成立，其名稱為Onco3，Inc.。Neon Therapeutics，Inc.是一家臨床階段免疫腫瘤學公司，也是新抗原領域的領導者，目標療法，致力於通過將免疫系統導向新抗原來改變癌症的治療。基因突變是癌症的一個標誌，可導致稱為新抗原的特異性免疫靶標。癌細胞中新抗原的存在及其在正常細胞中的缺乏使得它們成為癌症治療的引人注目的未開發靶標。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/NTGN/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NTGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTGN\",,,,,undefined,":{"symbol":"NTGN","market":"US","secType":"STK","nameCN":"Neon Therapeutics Inc.","latestPrice":3.07,"timestamp":1588708800000,"preClose":3.07,"halted":3,"volume":0,"delay":0,"floatShares":15196186,"shares":28966658,"eps":-2.681502,"marketStatus":"停牌","change":0,"latestTime":"05-21 17:47:19 EDT","open":3.07,"high":3.07,"low":3.07,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.681502,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1747872000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1530072000000,"exchange":"NASDAQ","adjPreClose":3.07,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTGN\",,,,,undefined,":{"symbol":"NTGN","floatShares":15196186,"roa":"-70.63%","roe":"-156.16%","lyrEps":-2.861539,"shares":28966658,"dividePrice":0,"high":3.07,"amplitude":0,"preClose":3.07,"low":3.07,"week52Low":0.88,"pbRate":"6.16","week52High":6.15,"institutionHeld":0,"latestPrice":3.07,"eps":-2.681502,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.681502,"open":3.07,"prevYearClose":1.18},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.neontherapeutics.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0102},{"period":"1month","weight":0.1262},{"period":"3month","weight":-0.0328},{"period":"6month","weight":-0.0014},{"period":"1year","weight":0.1185},{"period":"ytd","weight":0.0116}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Neon Therapeutics, Inc.於2013年10月根據特拉華州法律註冊成立，其名稱為Onco3，Inc.。Neon Therapeutics，Inc.是一家臨床階段免疫腫瘤學公司，也是新抗原領域的領導者，目標療法，致力於通過將免疫系統導向新抗原來改變癌症的治療。基因突變是癌症的一個標誌，可導致稱為新抗原的特異性免疫靶標。癌細胞中新抗原的存在及其在正常細胞中的缺乏使得它們成為癌症治療的引人注目的未開發靶標。","exchange":"NASDAQ","name":"Neon Therapeutics Inc.","nameEN":"Neon Therapeutics Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NTGN\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NTGN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-05-01","symbol":"NTGN","fiscalQuarterEnding":"2020/03","expectedEps":-0.27,"name":null,"time":"盤前","type":"earning","dateTimestamp":1588305600000,"reportTimeType":"pre","actualEps":-0.58},{"market":"US","date":"2019-11-12","symbol":"NTGN","fiscalQuarterEnding":"2019/09","expectedEps":-0.61,"name":null,"time":"","type":"earning","dateTimestamp":1573534800000,"reportTimeType":"","actualEps":-0.68},{"market":"US","date":"2019-08-06","symbol":"NTGN","fiscalQuarterEnding":"2019/06","expectedEps":-0.81,"name":null,"time":"","type":"earning","dateTimestamp":1565064000000,"reportTimeType":"","actualEps":-0.79},{"market":"US","date":"2019-05-13","symbol":"NTGN","fiscalQuarterEnding":"2019/03","expectedEps":-0.71,"name":null,"time":"","type":"earning","dateTimestamp":1557720000000,"reportTimeType":"","actualEps":-0.76},{"market":"US","date":"2019-03-11","symbol":"NTGN","fiscalQuarterEnding":"2018/12","expectedEps":-0.73,"name":null,"time":"","type":"earning","dateTimestamp":1552276800000,"reportTimeType":"","actualEps":-0.84}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NTGN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NTGN\",market:\"US\",delay:false,,,undefined,":{}}}